.jpg?format=webp&width=780)
The study evaluated the feasibility and effectiveness of using a pulmonary artery pressure (PAP) sensor (CardioMEMS) to manage patients with left ventricular assist devices (LVADs) to reduce heart failure hospitalization. The study followed 101 LVAD patients with CardioMEMS sensors for six months and measured PAP, 6-minute walk distance, quality of life, and heart failure hospitalization rates. Patients who showed significant reductions in PAP had improvements in 6MWD, and those who maintained PAP below 20 mmHg had fewer heart failure hospitalizations. The study concluded that hemodynamic-guided management of LVAD patients with CardioMEMS is feasible and may result in functional and clinical benefits. Prospective evaluation of ambulatory hemodynamic management in LVAD patients is warranted.
Like
Save
Share